Samsung Biologics Co.,Ltd. (207940.KS)
KSE - KSE Delayed price. Currency in KRW
Add to watchlist
At close: 03:30PM KST
Loading interactive chart…
- PR Newswire
Samsung Biologics Reports First Quarter 2024 Financial Results
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2024.
- PR Newswire
Samsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC)
Samsung Life Science Fund, created jointly between Samsung Biologics (KRX: 207940.KS), Samsung Bioepis, and Samsung C&T (KRX: 028260.KS), and managed by Samsung Ventures, and BrickBio, Inc. announced Samsung's investment in BrickBio, a preclinical-stage biopharmaceutical company focused on developing precision biologics using an expanded genetic code.
- Thomson Reuters StreetEvents
Q4 2023 Rapid Micro Biosystems Inc Earnings Call
Q4 2023 Rapid Micro Biosystems Inc Earnings Call
© 2024 Yahoo. All rights reserved.